Four-month clofazimine regimen for susceptible pulmonary TB: a randomized clinical trial.
Shafiq N, Kumar A, Vohra V, Khuller GK, Singh M, Kaur A, Gulati N, Chopra V, Gupta A, Kaushal S, Singh A, Aggarwal AN, Mohindra R, Raju R, Sawhney H, Goel D, Khurana AK, Khadanga S, Bansal A, Malhotra P, Gupta AK, Kansal D, Dadhwal DS, Sethi S, Saini VK, Aggarwal D, Singh PJ, Sabharwal M, Kumar L, Khayyam KU, Kushwaha D, Mittal V, Jain S, Chhabria BA, Kaur S, Taneja A, Pathak P, Gupta A, Bral R, Kumar A, Bhandari RK, Pandey AK, Rather I, Malhotra S.
Shafiq N, et al. Among authors: kaur s.
J Antimicrob Chemother. 2025 Aug 1;80(8):2100-2108. doi: 10.1093/jac/dkaf176.
J Antimicrob Chemother. 2025.
PMID: 40478219
Clinical Trial.